title: Q: Should N-acetylcysteine be used routinely to prevent contrast-induced acute kidney injury?
authors.affiliation: Division of Cardiology, Department of Medicine, Baystate Medical Center,Tufts University School of Medicine, Springfield, MA, USA.
authors.forename: Senthil K
authors.initials: SK
authors.lastname: Sivalingam
authors.forename: Mini V
authors.initials: MV
authors.lastname: Hariharan
authors.forename: Gregory L
authors.initials: GL
authors.lastname: Braden
authors.forename: Benjamin J
authors.initials: BJ
authors.lastname: Freda
mesh_terms: D000111:Acetylcysteine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D058186:Acute Kidney Injury / Q000139:chemically induced / Q000517:prevention & control*; D061605:Administration, Intravenous; D000707:Anaphylaxis / Q000139:chemically induced; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D017410:Practice Guidelines as Topic; D018570:Risk Assessment
chemical_list: D003287:Contrast Media; D000111:Acetylcysteine